Overview
Linjiang Tong practices practicing medicine in Shanghai, China.
Tong is highly rated in 1 condition, according to our data. Their clinical expertise encompasses EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and B-Cell Lymphoma.
They are actively involved in clinical research, co-authoring 56 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Linjiang I. Tong
Is Linjiang I. Tong a top-rated expert for EGFR Positive Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Linjiang I. Tong is classified as an Advanced expert for EGFR Positive Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Linjiang I. Tong participate in research or clinical trials?
Yes. Linjiang I. Tong has published 56 articles and abstracts on conditions like EGFR Positive Lung Cancer. You can view a list of Linjiang I. Tong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- EGFR Positive Lung Cancer
- Experienced
- B-Cell LymphomaTong isExperienced. Learn about B-Cell Lymphoma.
- Lung CancerTong isExperienced. Learn about Lung Cancer.
- Non-Hodgkin LymphomaTong isExperienced. Learn about Non-Hodgkin Lymphoma.
- Non-Small Cell Lung Cancer (NSCLC)